72 related articles for article (PubMed ID: 7857777)
1. kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753.
Gottschlich R; Krug M; Barber A; Devant RM
Chirality; 1994; 6(8):685-9. PubMed ID: 7857777
[TBL] [Abstract][Full Text] [Related]
2. The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
Gottschlich R; Barber A; Bartoszyk GD; Seyfried CA
Drugs Exp Clin Res; 1995; 21(5):171-4. PubMed ID: 8846746
[TBL] [Abstract][Full Text] [Related]
3. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
4. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
5. Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.
Kumar V; Guo D; Marella M; Cassel JA; Dehaven RN; Daubert JD; Mansson E
Bioorg Med Chem Lett; 2008 Jun; 18(12):3667-71. PubMed ID: 18487043
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective synthesis and structure-affinity relationships of bicyclic kappa receptor agonists.
Kracht D; Rack E; Schepmann D; Fröhlich R; Wünsch B
Org Biomol Chem; 2010 Jan; 8(1):212-25. PubMed ID: 20024152
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
[TBL] [Abstract][Full Text] [Related]
8. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
Binder W; Walker JS
Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
[TBL] [Abstract][Full Text] [Related]
9. Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists.
Subramanian G; Paterlini MG; Larson DL; Portoghese PS; Ferguson DM
J Med Chem; 1998 Nov; 41(24):4777-89. PubMed ID: 9822548
[TBL] [Abstract][Full Text] [Related]
10. Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonists.
Chu GH; Gu M; Cassel JA; Belanger S; Stabley GJ; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2006 Feb; 16(3):645-8. PubMed ID: 16263278
[TBL] [Abstract][Full Text] [Related]
11. The kappa-opioid receptor agonist asimadoline inhibits epithelial transport in mouse trachea and colon.
Schreiber R; Bartoszyk GD; Kunzelmann K
Eur J Pharmacol; 2004 Oct; 503(1-3):185-90. PubMed ID: 15496313
[TBL] [Abstract][Full Text] [Related]
12. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
Hjorth SA; Thirstrup K; Schwartz TW
Mol Pharmacol; 1996 Oct; 50(4):977-84. PubMed ID: 8863844
[TBL] [Abstract][Full Text] [Related]
13. Structure/activity studies related to 2-(3,4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]acetamides: a novel series of potent and selective kappa-opioid agonists.
Barlow JJ; Blackburn TP; Costello GF; James R; Le Count DJ; Main BG; Pearce RJ; Russell K; Shaw JS
J Med Chem; 1991 Nov; 34(11):3149-58. PubMed ID: 1659636
[TBL] [Abstract][Full Text] [Related]
14. Arylacetamides as peripherally restricted kappa opioid receptor agonists.
Kumar V; Marella MA; Cortes-Burgos L; Chang AC; Cassel JA; Daubert JD; DeHaven RN; DeHaven-Hudkins DL; Gottshall SL; Mansson E; Maycock AL
Bioorg Med Chem Lett; 2000 Nov; 10(22):2567-70. PubMed ID: 11086731
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
[TBL] [Abstract][Full Text] [Related]
16. Arylacetamide kappa-opioid receptor agonists produce a tonic- and use-dependent block of tetrodotoxin-sensitive and -resistant sodium currents in colon sensory neurons.
Joshi SK; Lamb K; Bielefeldt K; Gebhart GF
J Pharmacol Exp Ther; 2003 Oct; 307(1):367-72. PubMed ID: 12954815
[TBL] [Abstract][Full Text] [Related]
17. Arylacetamide kappa opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activity.
Le Bourdonnec B; Ajello CW; Seida PR; Susnow RG; Cassel JA; Belanger S; Stabley GJ; DeHaven RN; DeHaven-Hudkins DL; Dolle RE
Bioorg Med Chem Lett; 2005 May; 15(10):2647-52. PubMed ID: 15863335
[TBL] [Abstract][Full Text] [Related]
18. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
19. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
[TBL] [Abstract][Full Text] [Related]
20. Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat.
Gu B; Fraser MO; Thor KB; Dolber PC
J Urol; 2004 Jan; 171(1):472-7. PubMed ID: 14665958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
